Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Nivolumab plus ipilimumab achieves durable responses and has manageable safety in metastatic RCC.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου